RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Advanced Glycation End Products: Do They Impair Bone Health in Diabetes?
2022-10-01 Papachristou, Stella; Rizzo, Manfredi; Papanas, Nikolaos
Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes
2022-07-01 Rizzo, Manfredi; Cosentino, Francesco; Mantzoros, Christos
Cardiometabolic alterations in the interplay of covid-19 and diabetes: Current knowledge and future avenues
2021-01-01 Rizvi A.A.; Janez A.; Rizzo M.
Challenges and opportunities on lipid metabolism disorders diagnosis and therapy: Novel insights and future perspective
2021-01-01 Fras Z.; Jug B.; Penson P.E.; Rizzo M.
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children
2019-01-01 Nikolic D.; Corina A.; Toth P.P.; Hammad L.; Rizzo M.
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
2023-11-15 Pantea Stoian, Anca; Bica, Ioana-Cristina; Salmen, Teodor; Al Mahmeed, Wael; Al-Rasadi, Khalid; Al-Alawi, Kamila; Banach, Maciej; Banerjee, Yajnavalka; Ceriello, Antonio; Cesur, Mustafa; Cosentino, Francesco; Firenze, Alberto; Galia, Massimo; Goh, Su-Yen; Janez, Andrej; Kalra, Sanjay; Kapoor, Nitin; Kempler, Peter; Lessan, Nader; Lotufo, Paulo; Mikhailidis, Dimitri P; Nibali, Luigi; Papanas, Nikolaos; Powell-Wiley, Tiffany; Rizvi, Ali A; Sahebkar, Amirhossein; Santos, Raul D; Toth, Peter P; Viswanathan, Vijay; Rizzo, Manfredi
COVID-19 and diabetes management: What should be considered?
2020-01-01 Ceriello A.; Stoian A.P.; Rizzo M.
Diabetes and COVID-19: A Tale of 2 Pandemics
2021-01-01 Rizvi A.A.; Janez A.; Al Mahmeed W.; Rizzo M.
Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
2020-01-01 Stoian A.P.; Banerjee Y.; Rizvi A.A.; Rizzo M.
Editorial: Diet-microbe-host interactions in metabolic syndrome
2023-01-01 Gradisteanu Pircalabioru, Gratiela; Rizzo, Manfredi; Pantea Stoian, Anca; Chifiriuc, Mariana Carmen
Data di pubblicazione | Titolo | Autori | Tipologia | Autore(i) | File |
---|---|---|---|---|---|
1-ott-2022 | Advanced Glycation End Products: Do They Impair Bone Health in Diabetes? | Rizzo, Manfredi + | 01 - Contributo in rivista::1.11 Nota o commento | Papachristou, Stella; Rizzo, Manfredi; Papanas, Nikolaos | |
1-lug-2022 | Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes | Rizzo, Manfredi + | 01 - Contributo in rivista::1.11 Nota o commento | Rizzo, Manfredi; Cosentino, Francesco; Mantzoros, Christos | |
1-gen-2021 | Cardiometabolic alterations in the interplay of covid-19 and diabetes: Current knowledge and future avenues | Rizzo M. + | 01 - Contributo in rivista::1.11 Nota o commento | Rizvi A.A.; Janez A.; Rizzo M. | |
1-gen-2021 | Challenges and opportunities on lipid metabolism disorders diagnosis and therapy: Novel insights and future perspective | Rizzo M. + | 01 - Contributo in rivista::1.11 Nota o commento | Fras Z.; Jug B.; Penson P.E.; Rizzo M. | |
1-gen-2019 | Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children | Nikolic D.Rizzo M. + | 01 - Contributo in rivista::1.11 Nota o commento | Nikolic D.; Corina A.; Toth P.P.; Hammad L.; Rizzo M. | |
15-nov-2023 | Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review | Firenze, AlbertoGalia, MassimoRizzo, Manfredi + | 01 - Contributo in rivista::1.11 Nota o commento | Pantea Stoian, Anca; Bica, Ioana-Cristina; Salmen, Teodor; Al Mahmeed, Wael; Al-Rasadi, Khalid; Al-Alawi, Kamila; Banach, Maciej; Banerjee, Yajnavalka; Ceriello, Antonio; Cesur, Mustafa; Cosentino, Francesco; Firenze, Alberto; Galia, Massimo; Goh, Su-Yen; Janez, Andrej; Kalra, Sanjay; Kapoor, Nitin; Kempler, Peter; Lessan, Nader; Lotufo, Paulo; Mikhailidis, Dimitri P; Nibali, Luigi; Papanas, Nikolaos; Powell-Wiley, Tiffany; Rizvi, Ali A; Sahebkar, Amirhossein; Santos, Raul D; Toth, Peter P; Viswanathan, Vijay; Rizzo, Manfredi | |
1-gen-2020 | COVID-19 and diabetes management: What should be considered? | Rizzo M. + | 01 - Contributo in rivista::1.11 Nota o commento | Ceriello A.; Stoian A.P.; Rizzo M. | |
1-gen-2021 | Diabetes and COVID-19: A Tale of 2 Pandemics | Rizzo M. + | 01 - Contributo in rivista::1.11 Nota o commento | Rizvi A.A.; Janez A.; Al Mahmeed W.; Rizzo M. | |
1-gen-2020 | Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management | Rizzo M. + | 01 - Contributo in rivista::1.11 Nota o commento | Stoian A.P.; Banerjee Y.; Rizvi A.A.; Rizzo M. | |
1-gen-2023 | Editorial: Diet-microbe-host interactions in metabolic syndrome | Rizzo, Manfredi + | 01 - Contributo in rivista::1.11 Nota o commento | Gradisteanu Pircalabioru, Gratiela; Rizzo, Manfredi; Pantea Stoian, Anca; Chifiriuc, Mariana Carmen |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- Articolo in rivista 31
Data di pubblicazione
- 2023 7
- 2022 9
- 2021 10
- 2020 2
- 2019 2
- 2017 1
Editore
- MDPI 6
- Elsevier Ireland Ltd 3
- Adis 2
- ELSEVIER IRELAND LTD 2
- ELSEVIER SCIENCE INC 2
- TAYLOR & FRANCIS LTD 2
- GEORG THIEME VERLAG KG 1
- John Wiley and Sons Ltd 1
- Mary Ann Liebert Inc. 1
- MDPI AG 1
Rivista
- DIABETES THERAPY 3
- INTERNATIONAL JOURNAL OF CARDIOLOGY 3
- INTERNATIONAL JOURNAL OF MOLECULA... 3
- JOURNAL OF DIABETES AND ITS COMPL... 3
- DIABETES RESEARCH AND CLINICAL PR... 2
- EXPERT OPINION ON DRUG SAFETY 2
- METABOLITES 2
- ADVANCES IN THERAPY 1
Keyword
- Humans 11
- COVID-19 6
- Diabetes Mellitus 6
- diabetes 5
- obesity 4
- SARS-CoV-2 4
- Blood Glucose 3
- Diabetes Complications 3
- Hypoglycemic Agents 3
- Obesity 3
Lingua
- eng 31
Accesso al fulltext
- reserved 16
- open 14
- partially open 1